Zimmer Biomet is committed to good corporate governance and believes that an attentive, performing Board is a tangible competitive advantage. Within this section of Zimmer Biomet's website, you will find the following information on:

Principles

Code of Business Conduct and Ethics PDF
Code of Ethics for CEO and Senior Financial Officers PDF
Board Policy on Ratification of Independent Registered Public Accounting Firm PDF
Board Policy on Stockholder Rights Plans PDF
Corporate Governance Guidelines PDF
Policy Statement on Conflict Minerals PDF
Statement of Engagement on Public Policy Issues PDF

Committees

Audit Committee Charter PDF
Compensation and Management Development Committee Charter PDF
Corporate Governance Committee Charter PDF
Quality, Regulatory and Technology Committee Charter PDF

Committees at a Glance

  Audit Compensation and Management Development Corporate Governance Quality, Regulatory and Technology
Christopher B. Begley     Member of Compensation and Management Development Committee   Member of Quality, Regulatory and Technology Committee
Betsy J. Bernard   Member of Audit Committee   Committee Chair for Corporate Governance Committee  
Gail K. Boudreaux   Member of Audit Committee   Member of Corporate Governance Committee  
David C. Dvorak          
Michael J. "Mick" Farrell     Member of Compensation and Management Development Committee Member of Corporate Governance Committee  
Larry C. Glasscock   Chairman of the Board Member of Audit Committee   Member of Corporate Governance Committee  
Robert A. Hagemann   Committee Chair for Audit Committee     Member of Quality, Regulatory and Technology Committee
Arthur J. Higgins     Committee Chair for Compensation and Management Development Committee   Member of Quality, Regulatory and Technology Committee
Arthur J. Higgins President, Chief Executive Officer and Director
Depomed, Inc.

Director Since 2007

President, Chief Executive Officer and a member of the board of directors of Depomed, Inc. since March 2017.  Consultant, Blackstone Healthcare Partners of the Blackstone Group since June 2010.  Previously, Mr. Higgins served as Chairman of the Board of Management of Bayer HealthCare AG from January 2006 to May 2010 and Chairman of the Bayer HealthCare Executive Committee from July 2004 to May 2010.  Prior to joining Bayer HealthCare in 2004, Mr. Higgins served as Chairman, President and Chief Executive Officer of Enzon Pharmaceuticals, Inc. from 2001 to 2004.  Prior to that, Mr. Higgins spent 14 years with Abbott Laboratories, most recently as President of the Pharmaceutical Products Division from 1998 to 2001.  He graduated from Strathclyde University, Scotland and holds a B.S. in biochemistry.

Other Public Board Memberships

  • Depomed, Inc.
  • Ecolab Inc.
  • Past director of Endo International plc (until March 2017)
  • Past director of Resverlogix Corp. (until February 2014)

Other Relevant Experience

  • Past director of the Pharmaceutical Research and Manufacturers of America
  • Past member of the Council of the International Federation of Pharmaceutical Manufacturers and Associations
  • Past president of the European Federation of Pharmaceutical Industries and Associations

 

Michael W. Michelson     Member of Compensation and Management Development Committee   Member of Quality, Regulatory and Technology Committee
Cecil B. Pickett Ph.D.     Member of Compensation and Management Development Committee   Committee Chair for Quality, Regulatory and Technology Committee
Jeffrey K. Rhodes   Member of Audit Committee   Member of Corporate Governance Committee  
Chairman of the Board = Chairman of the Board      Chair = Chair     Committee Member = Member


Print page

Email page